Reiss Edwards Limited

We represented a American Venture Capitalist company, with speciality in biotechnology ventures, with an asset value of around 9 Billion USD. They contacted us requesting options to expand to the UK market, with plans to engage/invest with the 31% market share the UK has of Europe’s Biotech companies. The company instructed Reiss Edwards to assist via the Global Business Mobility route under the Expansion Worker sub category. The application was granted under the new rules and the company is now taking steps to set up a subsidiary branch in the UK. Following submission of the application, the Home Office indicated they may refuse the application. In 2020, the company had rebranded and split into parts for legitimate tax reasons. The decision maker understood this to mean that they did not meet the requirement of having operating overseas for at least 3 years. We were given 10 days to respond or withdraw and apply at a later date. Following further engagement with the client, we decided